National Bank Of Canada Ab Cellera Biologics Inc. Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, National Bank Of Canada holds 74,901 shares of ABCL stock, worth $174,519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,901
Previous 65,097
15.06%
Holding current value
$174,519
Previous $168,000
30.36%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ABCL
# of Institutions
165Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$64.1 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$28.5 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$24.8 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$18.5 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$17.1 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $664M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...